Response to PD-1 inhibitor in SMARCB1‑deficient undifferentiated rectal carcinoma with low TMB, proficient MMR and BRAF V600E mutation: a case report and literature review.
Journal Information
Full Title: Diagn Pathol
Abbreviation: Diagn Pathol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Ethics approval and consent to participateThe use of human samples was approved by the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. The data used in this research are part of standard-of-care hospital routine. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
Funding Disclosure
Evidence found in paper:
"Funding This work was supported by National Natural Science Foundation of China (NSFC) No. 81903019 and CAMS Innovation Fund for Medical Sciences (CIFMS) No. 2021-I2M-C&TA-017."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025